KURA CIK: 1422143

Kura Oncology, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
67.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−131
FY22:
−140
FY23:
−166
FY24:
−193
FY25:
−304
(positive)
Change from FY21 to FY25
millions USD
FY21:
−129
FY22:
−135
FY23:
−150
FY24:
−169
FY25:
−276
(positive)
Change from FY21 to FY25
millions USD
FY21:
−130
FY22:
−136
FY23:
−153
FY24:
−172
FY25:
−278
(positive)
Change from FY21 to FY25
millions USD
FY21:
−130
FY22:
−136
FY23:
−153
FY24:
−174
FY25:
−279

All amounts in millions USD Data sources:SEC EDGARTwelve Data